NCT00300469
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
See it on ClinicalTrials.gov ↗609 people
51.1%
48.9%
311 womenmiddle line = equal numbers298 men
- Phase
- PHASE3
- Paid for by
- Abbott
- Finished
- —
- Health conditions
- Mixed Dyslipidemia, Coronary Heart Disease, Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- Not reported
- Age 65+
- 19.5%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Women who are pregnant or plan on becoming pregnant, or women who are lactating.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Women who are pregnant or plan on becoming pregnant, or women who are lactating.”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Subjects must agree to utilize adequate birth control methods and to adhere to the American Heart Association (AHA) diet”
Study titles and rules are shown in their original English.